Downsizing a BTK PROTAC yields a G-loop independent molecular glue that blurs the boundary between degrader classes
Abstract Targeted protein degradation (TPD) represents a novel and rapidly evolving therapeutic strategy that harnesses the cell's own proteolytic systems to selectively eliminate disease-associated proteins. In this study, we serendipitously discovered and characterized the first Bruton's tyrosine kinase (BTK)-targeting molecular glue, PS-10. PS-10 efficiently degrades BTK with a DC 50 in the single-digit nanomolar range and a D max exceeding 95%, despite displaying negligible binary binding affinity for the kinase itself. Cryo-EM and computational modeling revealed that PS-10 induces a protein-protein interaction (PPI) interface between CRBN and BTK stabilized by an induced-fit rotation of the BTK N-lobe, with extensive PPIs distinct from previously known CRBN-substrate complexes. Crucially, global proteomics and mutational mapping across other kinases (CSK, AURKA, LIMK1, and TEC) demonstrated that this degradation mechanism extends beyond BTK and relies on a diverse set of PPI residues. These findings underscore a remarkable structural plasticity, indicating that productive E3-neosubstrate PPIs can be dynamically achieved via distinct structural trajectories. Ultimately, this demonstrates that rigid, pre-existing degrons are not mandatory; rather, the existence of even a weak target binder presents a distinct opportunity to exploit plastic PPI interfaces to maximize cooperativity, establishing a novel and generalizable blueprint for rational molecular glue design.
Authors
- Ran Cheng (ORCID: https://orcid.org/0009-0007-3906-6110)
- Jennifer Ann Woyach (ORCID: https://orcid.org/0000-0002-3403-9144)
- Hanfeng Lin (ORCID: https://orcid.org/0000-0002-3172-5616)
- Shrilekha Misra (ORCID: https://orcid.org/0000-0001-9656-932X)
- Yang Gao (ORCID: https://orcid.org/0000-0003-3209-4788)
- Jin Wang (ORCID: https://orcid.org/0000-0003-3625-7919)
- Andrew Mitchell (ORCID: https://orcid.org/0000-0002-0142-2868)
- Xin Yu (ORCID: https://orcid.org/0000-0003-1986-9040)
- Xiaoli Qi (ORCID: https://orcid.org/0009-0007-4531-7449)
- Lukáš Maršálek
- Deepak Pathak
Institutions
- Baylor College of Medicine (US)
- The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
- The Ohio State University (US)
- Rice University (US)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-06
- DOI
- https://doi.org/10.21203/rs.3.rs-11296825/v1
- Primary Topic
- Protein Degradation and Inhibitors
- Type
- preprint
Funders
- Cancer Prevention and Research Institute of Texas
- National Institutes of Health